Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2013-12-10

Clinical Trial Update: Clinical Trial of SAHA in Patients With Breast Cancer [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial of SAHA (vorinostat) in patients with breast cancer is reported, with sponsor National University Hospital, Singapore and an unknown …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SAHA (vorinostat)

Snippet

Sponsor: National University Hospital, Singapore | Conditions: Breast Cancer | Phase 1, Phase 2 | Status: UNKNOWN